» Articles » PMID: 36483104

Monkeypox: An Emerging Zoonotic Pathogen

Overview
Journal World J Virol
Date 2022 Dec 9
PMID 36483104
Authors
Affiliations
Soon will be listed here.
Abstract

Monkeypox virus (MPXV), which belongs to the orthopoxvirus genus, causes zoonotic viral disease. This review discusses the biology, epidemiology, and evolution of MPXV infection, particularly cellular, human, and viral factors, virus transmission dynamics, infection, and persistence in nature. This review also describes the role of recombination, gene loss, and gene gain in MPXV evol-vement and the role of signal transduction in MPXV infection and provides an overview of the current access to therapeutic options for the treatment and prevention of MPXV. Finally, this review highlighted gaps in knowledge and proposed future research endeavors to address the unresolved questions.

Citing Articles

Evolutionary variation of the monkeypox virus detected for the first time in Nantong, Jiangsu.

Ji X, Liang R, Bao C, Cai X, Chen S, Chen L Virol J. 2024; 21(1):334.

PMID: 39716235 PMC: 11665207. DOI: 10.1186/s12985-024-02616-3.

References
1.
Gong Q, Wang C, Chuai X, Chiu S . Monkeypox virus: a re-emergent threat to humans. Virol Sin. 2022; 37(4):477-482. PMC: 9437600. DOI: 10.1016/j.virs.2022.07.006. View

2.
Realegeno S, Puschnik A, Kumar A, Goldsmith C, Burgado J, Sambhara S . Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation. J Virol. 2017; 91(11). PMC: 5432867. DOI: 10.1128/JVI.00011-17. View

3.
Shafaati M, Zandi M . Monkeypox virus neurological manifestations in comparison to other orthopoxviruses. Travel Med Infect Dis. 2022; 49:102414. PMC: 9528230. DOI: 10.1016/j.tmaid.2022.102414. View

4.
Mucker E, Shamblin J, Raymond J, Twenhafel N, Garry R, Hensley L . Effect of Monkeypox Virus Preparation on the Lethality of the Intravenous Cynomolgus Macaque Model. Viruses. 2022; 14(8). PMC: 9413320. DOI: 10.3390/v14081741. View

5.
Demaria O, Gauthier L, Debroas G, Vivier E . Natural killer cell engagers in cancer immunotherapy: Next generation of immuno-oncology treatments. Eur J Immunol. 2021; 51(8):1934-1942. DOI: 10.1002/eji.202048953. View